SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in Psychiatry - 11(2020) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peter M. Kreuzer [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Clinical psychiatry |
|---|
| doi: |
10.3389/fpsyt.2020.00550 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ038881454 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ038881454 | ||
| 003 | DE-627 | ||
| 005 | 20230502133719.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpsyt.2020.00550 |2 doi | |
| 035 | |a (DE-627)DOAJ038881454 | ||
| 035 | |a (DE-599)DOAJ0d9506fcfbd447db8c8b7bca74a0e081 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC435-571 | |
| 100 | 0 | |a Peter M. Kreuzer |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course. | ||
| 650 | 4 | |a corona virus | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a clinical psychiatry | |
| 650 | 4 | |a hospital management | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a pandemia | |
| 653 | 0 | |a Psychiatry | |
| 700 | 0 | |a Thomas C. Baghai |e verfasserin |4 aut | |
| 700 | 0 | |a Rainer Rupprecht |e verfasserin |4 aut | |
| 700 | 0 | |a Markus Wittmann |e verfasserin |4 aut | |
| 700 | 0 | |a Dagmar Steffling |e verfasserin |4 aut | |
| 700 | 0 | |a Michael Ziereis |e verfasserin |4 aut | |
| 700 | 0 | |a Marc Zowe |e verfasserin |4 aut | |
| 700 | 0 | |a Helmut Hausner |e verfasserin |4 aut | |
| 700 | 0 | |a Berthold Langguth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Psychiatry |d Frontiers Media S.A., 2010 |g 11(2020) |w (DE-627)DOAJ000071250 |x 16640640 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fpsyt.2020.00550 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/0d9506fcfbd447db8c8b7bca74a0e081 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/article/10.3389/fpsyt.2020.00550/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1664-0640 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 | ||